FROM EIR DAILY ALERT
Soros-Financed Drug Legalization Conference Begins in Mexico, Targets U.S.-Mexico Relations
Oct. 29, 2018 (EIRNS)—Just a month from the Dec. 1 inauguration of Mexico’s new President Andrés Manuel López Obrador, or AMLO, Mexico City today is the venue for a very large, three-day international pro-drug legalization conference, sponsored by George Soros’s Open Society Foundation (OSF) and the German Social Democracy’s Friedrich Ebert Stiftung, among others. Its focus is the British Empire’s anti-people and pro-population reduction agenda—an Opium War against the Americas—depicted as part of the “green wave moving through the region.”
The Seventh Latin American Conference and Second Mexican Conference on Drug Policy is intended to not only intervene into Mexico’s internal affairs, shaping the AMLO government’s policies, but also to create a point of conflict with the Trump Administration, collaboration with which is essential to solve the region’s most pressing problems. President Donald Trump has made clear he opposes any drug legalization in Mexico.
The conference has all of Ibero-America as its target; but the fact that it takes place now in Mexico makes its geopolitical aims clear. It also bears the pawprints of Olga Sanchez Cordero, AMLO’s Interior Secretary-designate, a Soros fellow-traveler and loud proponent of drug legalization and negotiation with drug cartels to “pacify” Mexico.
Sponsored also by Mexico’s Foreign Ministry, the conference couches its drug legalization thrust as concern for “harm reduction,” and defending human rights, alleviating poverty, social exclusion, and discrimination of women and young people. All these problems, according to the conference organizers, are allegedly caused by efforts to combat the drug cartels, eradicate marijuana and poppy cultivation, and promote crop substitution.
Thus, the question to be posed by one of the many panels, is “what can civil society do when the government does not want to make a change in drug policy?... As the green wave moves in the region, we see the effects of novel drug policies”—those that don’t “criminalize” drug use or production. These include “cannabis regulation models and poppy regulation proposals” in different countries, and evaluating their implementation “from the local to the international level.”
